Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed360%
unknown240%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

Cluster-Randomized Asthma FeNO Trial

NCT05853809
completed

FeNO Hairdressers Pilot

NCT05507944
unknown

Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment

NCT05553379
completed

Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation

NCT02561351
completednot_applicable

FeNO After Hypoxia in Asthma Patients

NCT02391090

Clinical Trials (5)

Showing 5 of 5 trials
NCT05853809Not Applicable

Cluster-Randomized Asthma FeNO Trial

Unknown
NCT05507944

FeNO Hairdressers Pilot

Completed
NCT05553379

Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment

Unknown
NCT02561351

Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation

Completed
NCT02391090Not Applicable

FeNO After Hypoxia in Asthma Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5